LIPT CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. LIPT Gen Silencer sind erhältlich als LIPT CRISPR/Cas9 Knockout Plasmide und LIPT Double Nickase Plasmide. LIPT CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
LIPT CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
LIPT1 CRISPR/Cas9 KO Plasmid (h) | sc-408883 | h | Gene Knockout | GFP | 0 | ||
LIPT1 HDR Plasmid (h) | sc-408883-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
LIPT1 Double Nickase Plasmid (h) | sc-408883-NIC | h | Gene Knockout | Puromycin | 0 | ||
LIPT1 Double Nickase Plasmid (h2) | sc-408883-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
LIPT1 CRISPR/Cas9 KO Plasmid (m) | sc-436934 | m | Gene Knockout | GFP | 0 | ||
LIPT1 HDR Plasmid (m) | sc-436934-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
LIPT1 Double Nickase Plasmid (m) | sc-436934-NIC | m | Gene Knockout | Puromycin | 0 | ||
LIPT1 Double Nickase Plasmid (m2) | sc-436934-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
LIPT2 CRISPR/Cas9 KO Plasmid (h) | sc-415754 | h | Gene Knockout | GFP | 0 | ||
LIPT2 HDR Plasmid (h) | sc-415754-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
LIPT2 Double Nickase Plasmid (h) | sc-415754-NIC | h | Gene Knockout | Puromycin | 0 | ||
LIPT2 Double Nickase Plasmid (h2) | sc-415754-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
LIPT2 CRISPR/Cas9 KO Plasmid (m) | sc-426421 | m | Gene Knockout | GFP | 0 | ||
LIPT2 HDR Plasmid (m) | sc-426421-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
LIPT2 Double Nickase Plasmid (m) | sc-426421-NIC | m | Gene Knockout | Puromycin | 0 | ||
LIPT2 Double Nickase Plasmid (m2) | sc-426421-NIC-2 | m | Gene Knockout | Puromycin | 0 |
LIPT CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
LIPT1 CRISPR Activation Plasmid (h) | sc-408883-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT1 CRISPR Activation Plasmid (h2) | sc-408883-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT1 Lentiviral Activation Particles (h) | sc-408883-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT1 Lentiviral Activation Particles (h2) | sc-408883-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT1 CRISPR Activation Plasmid (m) | sc-436934-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT1 CRISPR Activation Plasmid (m2) | sc-436934-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT1 Lentiviral Activation Particles (m) | sc-436934-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT1 Lentiviral Activation Particles (m2) | sc-436934-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT2 CRISPR Activation Plasmid (h) | sc-415754-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT2 CRISPR Activation Plasmid (h2) | sc-415754-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT2 Lentiviral Activation Particles (h) | sc-415754-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT2 Lentiviral Activation Particles (h2) | sc-415754-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT2 CRISPR Activation Plasmid (m) | sc-426421-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT2 CRISPR Activation Plasmid (m2) | sc-426421-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT2 Lentiviral Activation Particles (m) | sc-426421-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
LIPT2 Lentiviral Activation Particles (m2) | sc-426421-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |